Pegcetacoplan for 52 Weeks Maintains Proteinuria Reduction Regardless of Immunosuppressant Use or Nephrotic-Range Proteinuria at Baseline: VALIANT Subgroup Analysis
Carla Nester, Fádi Fakhouri, Daniel P. Gale, Andrew S. Bomback, Christoph Licht, Giuseppe Remuzzi, Nicole C. A. J. van de Kar, K. Gordon, Anwesha Mukherjee, Johan Szamosi, Lucía Quintana, Matthew C. Pickering
Marina Vivarelli, Andrew S. Bomback, Gema Ariceta, Antonio Mastrangelo, Carla Nester, Giuseppe Remuzzi, Nicole C. A. J. van de Kar, Zhongshen Wang, Johan Szamosi, Dima Decker, Lenny Gallardo, Fádi Fakhouri
Carla Nester, Andrew S. Bomback, Gema Ariceta, Yahsou Delmas, Bradley P. Dixon, Daniel P. Gale, Larry A. Greenbaum, Seung Hyeok Han, Nicole M. Isbel, Christoph Licht, Antonio Mastrangelo, Masashi Mizuno, Maria Izabel Neves de Holanda, Matthew C. Pickering, Giuseppe Remuzzi, Nicole C. A. J. van de Kar, Marina Vivarelli, Patrick D. Walker, Dean Wallace, Daniel Zecher,
Anna Rosenberg, Tiia Ngandu, Minna Rusanen, Riitta Antikaínen, Lars Bäckman, Satu Havulinna, Tuomo Hänninen, Tiina Laatikainen, Jenni Lehtisalo, Esko Levälahti, Jaana Lindström, Teemu Paajanen, Markku Peltonen, Hilkka Soininen, Anna Stigsdotter‐Neely, Timo Strandberg, Jaakko Tuomilehto, Alina Solomon, Miia Kivipelto
Philippe Moreau, David S. Siegel, Hartmut Goldschmidt, Rubén Niesvizky, Sara Bringhen, Robert Z. Orlowski, Julie Blædel, Zhao Yang, Meletios A Dimopoulos
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.